Brian Nichols

Brian Nichols

InvestorPlace Contributor

Recent Articles

1 Metric That Should Scare Netflix, Inc. Stock Owners

By Brian Nichols, InvestorPlace Contributor

Engagement is slipping at NFLX, and that's not a good sign for Netflix stock as competition closes in.

5 Reasons AT&T Inc. Stock Isn’t Buckling Like Everything Else (T)

By Brian Nichols, InvestorPlace Contributor

AT&T stock is a must own in 2016 and beyond, regardless of what happens with oil or in global markets.

Yahoo Stock: Mayer Has A Bazooka But Is Too Scared to Use It

By Brian Nichols, InvestorPlace Contributor

YHOO and Mayer are like deer in headlights, unable to see a bazooka that can save Yahoo stock.

Why Sprint Corp Stock Is Only Going to Get Worse (S)

By Brian Nichols, InvestorPlace Contributor

The Sprint stock price still hasn't found a bottom, and it still has a long way to fall from here.

Rite Aid Corporation: RAD Stock Is a Healthy Investment

By Brian Nichols, InvestorPlace Contributor

RAD stock is a buy right now, regardless of what happens with the Walgreens merger.

Baidu Inc vs. Alibaba Group Holding Ltd: Which Chinese Titan Is Best? (BIDU, BABA)

By Brian Nichols, InvestorPlace Contributor

You can't own BIDU and BABA in this turbulent market, but should certainly own one or the other.

7 Battered Biotech Stocks: Bargains or Busts?

By Brian Nichols, InvestorPlace Contributor

Biotech stocks have suffered big losses in 2016. Some are great buying opportunities, but the rest are just disasters.

FB Is Becoming More Like GOOGL, But Will Facebook Stock Follow?

By Brian Nichols, InvestorPlace Contributor

An experiment with new types of feed should open up Google-like advertising opportunities, which can only be good for FB stock.

Visa Stock: Can V Take Down PYPL?

By Brian Nichols, InvestorPlace Contributor

Visa stock and PayPal stock may be brought down ... just not by each other.

I Said Chipotle Stock Would Hit $400 – Now What? (CMG)

By Brian Nichols, InvestorPlace Contributor

The headache that began with E.coli and norovirus may be just the beginning of the nightmare for Chipotle stock (CMG).

Load More